Heterochromatin protein 1 expression is reduced in human thyroid malignancy (Q38993801)

8 September 2017

title

Heterochromatin protein 1 expression is reduced in human thyroid malignancy (English)

1 reference

8 September 2017

Tracy K Hale

1 reference

8 September 2017

Maria S Tretiakova

1 reference

8 September 2017

Sarah D Bond

1 reference

8 September 2017

David Wheeler

1 reference

8 September 2017

Alejandro Contreras

1 reference

8 September 2017

Masha Kocherginsky

1 reference

8 September 2017

Todd G Kroll

1 reference

8 September 2017

publication date

19 May 2014

1 reference

8 September 2017

published in

Laboratory Investigation

1 reference

8 September 2017

1 reference

8 September 2017

1 reference

8 September 2017

page(s)

788-795

1 reference

Nuclear structure in cancer cells

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

HP1: heterochromatin binding proteins working the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

Heterochromatin protein 1alpha: a hallmark of cell proliferation relevant to clinical oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

The role of YY1 in reduced HP1alpha gene expression in invasive human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

Prediction of central nervous system embryonal tumour outcome based on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

Analysis of HP1α regulation in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

Heterochromatin protein 1gamma epigenetically regulates cell differentiation and exhibits potential as a therapeutic target for various types of cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

The heterochromatin protein 1 family is regulated in prostate development and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

Gastrin-Releasing Peptide Signaling Alters Colon Cancer Invasiveness via Heterochromatin Protein 1Hsβ

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

Molecular diagnostics and predictors in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

MicroRNA Role in Thyroid Cancer Development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

MicroRNA expression profiles in thyroid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

Topoisomerase IIalpha in Wilms' tumour: gene alterations and immunoexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

The role of microRNA genes in papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

HP1-beta is required for development of the cerebral neocortex and neuromuscular junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

A requirement for dimerization of HP1Hsalpha in suppression of breast cancer invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

Genome-wide appraisal of thyroid cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

DNA copy number changes in thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2014.68

Reduced heterochromatin protein 1-beta (HP1beta) expression is correlated with increased invasive activity in human melanoma cells.

21 January 2018

1 reference

12 December 2020

The WHO histological classification of thyroid tumors: a commentary on the second edition

1 reference

12 December 2020

Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study

1 reference

12 December 2020

Down-regulation of HP1Hsalpha expression is associated with the metastatic phenotype in breast cancer

1 reference

12 December 2020

Variant-specific patterns and humoral regulation of HP1 proteins in human cells and tissues

1 reference

12 December 2020

Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity

1 reference

12 December 2020

10.1038/LABINVEST.2014.68

Identifiers

DOI

1 reference

Dimensions Publication ID

8 September 2017

1028116457

0 references

1 reference